- Exploration of carbamide derived pyrimidine-thioindole conjugates as potential VEGFR-2 inhibitors with anti-angiogenesis effect
-
The development of new small molecules from known structural motifs through molecular hybridization is one of the trends in drug discovery. In this connection, we have combined the two pharmacophoric units (pyrimidine and thioindole) in a single entity via molecular hybridization strategy along with introduction of urea functionality at C2 position of pyrimidine to increase the efficiency of H-bonding interactions. Among the synthesized conjugates 12a-aa, compound 12k was found to exhibit significant IC50 values 5.85, 7.87, 6.41 and 10.43 μM against MDA-MB-231 (breast), HepG2 (liver), A549 (lung) and PC-3 (prostate) cancer cell lines, respectively. All these compounds were further evaluated for their inhibitory activities against VEGFR-2 protein. The results specified that among the tested compounds, 12d, 12e, 12k, 12l, 12p, 12q, 12t and 12u prominently suppressed VEGFR-2, with IC50 values of 310–920 nM in association to the positive control (210 nM). Angiogenesis inhibition was evident by tube formation assay in HUVECs and cell-invasion by transwell assay. The mechanism of cellular toxicity on MDA-MB-231 was found through depolarisation of mitochondrial membrane potential, increased ROS production and subsequent DNA damage resulting in apoptosis induction. Moreover, clonogenic and wound healing assays designated the inhibition of colony formation and cell migration by 12k in a dose-dependent manner. Molecular docking studies also shown that compound 12k capably intermingled with catalytically active residues GLU-885, ASP-1046 of the VEGFR-2 through hydrogen-bonding interactions.
- Bhandari, Sonal,Bhargava, Suresh K.,Reddy, T. Srinivasa,Reddy, Velma Ganga,Sakla, Akash P.,Sana, Sravani,Shankaraiah, Nagula,Tokala, Ramya
-
-
- CYCLIC AMIDE DERIVATIVES AS INHIBITORS OF 11 - BETA - HYDROXYSTEROID DEHYDROGENASE AND USES THEREOF
-
The present invention relates to certain amide derivatives that have the ability to inhibit 11-β-hydroxysteroid dehydrogenase type 1 (11β-HSD-1) and which are therefore useful in the treatment of certain disorders that can be prevented or treated by inhibition of this enzyme. In addition the invention relates to the compounds, methods for their preparation, pharmaceutical compositions containing the compounds and the uses of these compounds in the treatment of certain disorders. It is expected that the compounds of the invention will find application in the treatment of conditions such as non-insulin dependent type 2 diabetes mellitus (NIDDM), insulin resistance, obesity, impaired fasting glucose, impaired glucose tolerance, lipid disorders such as dyslipidemia, hypertension and as well as other diseases and conditions.
- -
-
Paragraph 0293
(2015/06/17)
-
- CYCLIC AMIDE DERIVATIVES AS INHIBITORS OF 11 - BETA - HYDROXYSTEROID DEHYDROGENASE AND USES THEREOF
-
The present invention relates to certain amide derivatives that have the ability to inhibit 11-β-hydroxysteroid dehydrogenase type 1 (11β-HSD-1) and which are therefore useful in the treatment of certain disorders that can be prevented or treated by inhibition of this enzyme. In addition the invention relates to the compounds, methods for their preparation, pharmaceutical compositions containing the compounds and the uses of these compounds in the treatment of certain disorders. It is expected that the compounds of the invention will find application in the treatment of conditions such as non-insulin dependent type 2 diabetes mellitus (NIDDM), insulin resistance, obesity, impaired fasting glucose, impaired glucose tolerance, lipid disorders such as dyslipidemia, hypertension and as well as other diseases and conditions.
- -
-
Page/Page column 83
(2013/09/12)
-
- INDOLE AND INDAZOLE DERIVATIVES AS OREXIN RECEPTOR ANTAGONISTS
-
The invention relates to compounds of formula (I) wherein A, R1 to Rs have the meaning as cited in the description and the claims. Said compounds are useful as Orexin Receptor antagonists. The invention also relates to pharmaceutical compositions, the preparation of such compounds as well as the production and use as medicament.
- -
-
Page/Page column 47-48
(2011/11/30)
-
- An expeditious synthesis for γ-carboline analogue 4-aryl-1,3-thiazino[6,5-b]indole derivatives via the trifluoromethanesulfonic acid-promoted isomerization of 3-amidomethylthioindole intermediates to 2-indolyl sulfides
-
A highly efficient trifluoromethanesulfonic acid-mediated rearrangement of the benzoylaminomethylthio group of 3-benzoylaminomethylthioindoles (7a-e) to position 2 of the indole ring was developed. Thus, 2-benzoylaminomethylthioindoles (9a-e) were obtained in good yields and were involved as key intermediates in the synthesis of the new γ-carboline analogue ring system: 2,9-dihydro-4-aryl-1,3-thiazino[6,5-b]indole derivatives (11a-e). The target thiazinoindoles (11a-e) were prepared via 2-thiobenzoylaminomethylindoles (10a-e) in modified Bischler-Napieralski reactions.
- Csomós, Péter,Fodor, Lajos,Bernáth, Gábor,Csámpai, Antal,Sohár, Pál
-
experimental part
p. 1475 - 1480
(2009/04/11)
-
- 1-(AMINOALKYL)-3-SULFONYLINDOLE AND-INDAZOLE DERIVATIVES AS 5-HYDROXYTRYPTAMINE-6 LIGANDS
-
The present invention provides compounds of formula I and the use thereof for the treatment of central nervous system disorders related to or affected by the 5-HT6 receptor.
- -
-
-
- Cyclization of 2- and 3-indolylthiobenzoic, phenylacetic and nicotinic acids and esters to novel indole-containing tetracyclic ring systems
-
A series of 2- and 3-indolylthio benzoic, phenylacetic and nicotinic acids or esters were cyclized under dehydrative conditions affording several tetracyclic indole-containing ketones, several of which constitute the first reported examples of novel ring systems, such as the [1]benzothiepino[2,3-b] and [3,2-b]indole and the pyrido[3'2':5,6] and [3'4':5,6]thiopyrano[2,3-b] and [3,2-b]indole as well as the [3'2':5,6] and [3'4':5,6][1,3]thiazino[3,2- a]indole ring systems.
- Hamel, Pierre,Girard, Mario,Tsou, Nancy N.
-
p. 643 - 652
(2007/10/03)
-
- Derivatives of 3-Mercaptoindole - Synthesis of a Potent Vasoconstrictor, 3-(2-Imidazolin-2-ylthio)indole (Tinazoline)
-
Indoles are oxidatively coupled with various cyclic and acyclic thioureas using iodine to give rise to 3-(2-imidazolin-2-ylthio)indole, 1-30, 32 and 36-40.Similar products 33, 34 and 35 are respectively obtained from benzindole, 1,6,6-trimethyl-4,5,6,7-tetrahydroindole and 7-azaindole, while alkylation of 3-mercaptoindole 44 with chlormethyl imidazoline leads to 31.Among the products so obtained, 3-(2-imidazolin-2-ylthio)indole is a potent vasoconstrictor and the hydrochloride salt forms the active ingredient of VarsylR. 3-Mercaptoindole (44) readily obtained by alkali treatment of S-(3-indolyl)isothiourea (36) is converted into amine derivatives 47 and 52 and to the acids 53-55.Acid-catalysed cyclisation of 55 affords the expected thiopyranone (57), as well as the interesting isomeric ketone (58).A mechanism is proposed for this novel rearrangement. 3-Mercaptoindole (44) is also converted to α-methylaminoacid (64) via the hydantoin (63). 3-Mercaptoindole-2-carboxylic acid (65) obtained from 10 is transformed to a variety of methylated derivatives 66-72.The amino acid 75 arising by the action of ethylenimine on 65 is esterified to 76 and cyclised to the condensed thiazepinone (77).
- Nagarajan, K.,Arya, V. P.,Parthasarathy, T. N.,Shenoy, S. J.,Shah, R. K.,Kulkarni, Y. S.
-
p. 672 - 679
(2007/10/02)
-
- Substituted indoles
-
Substituted thioindoles and their sulfoxide and sulfone derivatives, useful as cardiac rate lowering agents and for other pharmacological properties, and precursors therefor.
- -
-
-